- Home
- TIPT vs CATX Comparison
TIPT vs CATX Comparison
Compare TIPT & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TIPT | CATX |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 653.2M | 609.4M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TIPT | CATX |
|---|---|---|
| Price | $16.22 | $5.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $12.20 |
| AVG Volume (30 Days) | 201.9K | ★ 1.6M |
| Earning Date | 06-09-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.41% | N/A |
| EPS Growth | N/A | ★ 29.31 |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $488,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $25.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.94 | $1.60 |
| 52 Week High | $27.38 | $6.16 |
Technical Indicators
Market Signals| Indicator | TIPT | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 36.29 | 57.49 |
| Support Level | N/A | $3.24 |
| Resistance Level | $18.39 | $5.39 |
| Average True Range (ATR) | 0.53 | 0.42 |
| MACD | -0.05 | -0.11 |
| Stochastic Oscillator | 15.74 | 46.83 |
Price Performance
Historical ComparisonAbout TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.